Literature DB >> 9192268

Large scale deletions in the GPC3 gene may account for a minority of cases of Simpson-Golabi-Behmel syndrome.

S Lindsay1, M Ireland, O O'Brien, J Clayton-Smith, J A Hurst, J Mann, T Cole, J Sampson, S Slaney, D Schlessinger, J Burn, G Pilia.   

Abstract

AIMS OF THE STUDY: To identify the proportion and type of deletions present in the glypican 3 (GPC3) gene in a group of patients with Simpson-Golabi-Behmel syndrome (SGBS). SUBJECTS AND METHODS: PCR analysis using primer pairs which amplify fragments from each of the eight exons of the GPC3 gene was carried out in a series of 18 families with SGBS (approximately half of reported cases).
RESULTS: Deletions were detected in only five families (one reported previously). We found deletions in all exons of the gene except exon 3.
CONCLUSIONS: Our results suggest that large scale deletions may be less common in SGBS than was originally thought. One patient, with an exon 4 and 5 deletion, lacked the characteristic facial dysmorphic features. This raises the possibility of involvement of GPC3 gene defects in a wider range of overgrowth disorders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192268      PMCID: PMC1050971          DOI: 10.1136/jmg.34.6.480

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  10 in total

1.  The importance of differentiating Simpson-Golabi-Behmel and Beckwith-Wiedemann syndromes.

Authors:  R Hughes-Benzie; J Allanson; A Hunter; T Cole
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

2.  A previously unrecognized X-linked syndrome of dysmorphia.

Authors:  J L Simpson; S Landey; M New; J German
Journal:  Birth Defects Orig Artic Ser       Date:  1975

3.  Glypicans: a growing trend.

Authors:  R Weksberg; J A Squire; D M Templeton
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

4.  Simpson-Golabi-Behmel syndrome associated with renal dysplasia and embryonal tumor: localization of the gene to Xqcen-q21.

Authors:  R M Hughes-Benzie; A G Hunter; J E Allanson; A E Mackenzie
Journal:  Am J Med Genet       Date:  1992 Apr 15-May 1

5.  Simpson-Golabi-Behmel syndrome: an X-linked encephalo-tropho-schisis syndrome.

Authors:  G Neri; R Marini; M Cappa; P Borrelli; J M Opitz
Journal:  Am J Med Genet       Date:  1988 May-Jun

6.  A new X-linked mental retardation-overgrowth syndrome.

Authors:  M Golabi; L Rosen
Journal:  Am J Med Genet       Date:  1984-01

7.  Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.

Authors:  G Pilia; R M Hughes-Benzie; A MacKenzie; P Baybayan; E Y Chen; R Huber; G Neri; A Cao; A Forabosco; D Schlessinger
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

8.  Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene.

Authors:  Z Q Wang; M R Fung; D P Barlow; E F Wagner
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

9.  A new X-linked dysplasia gigantism syndrome: identical with the Simpson dysplasia syndrome?

Authors:  A Behmel; E Plöchl; W Rosenkranz
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  Parental imprinting of the mouse insulin-like growth factor II gene.

Authors:  T M DeChiara; E J Robertson; A Efstratiadis
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

  10 in total
  9 in total

Review 1.  Glypicans: proteoglycans with a surprise.

Authors:  J Filmus; S B Selleck
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Familial neurofibromatosis type 1 associated with an overgrowth syndrome resembling Weaver syndrome.

Authors:  C J van Asperen; W C Overweg-Plandsoen; M H Cnossen; D A van Tijn; R C Hennekam
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

3.  Mapping of a new SGBS locus to chromosome Xp22 in a family with a severe form of Simpson-Golabi-Behmel syndrome.

Authors:  L M Brzustowicz; S Farrell; M B Khan; R Weksberg
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

Review 4.  Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour.

Authors:  R H Scott; C A Stiller; L Walker; N Rahman
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

5.  A patient with Simpson-Golabi-Behmel syndrome and hepatocellular carcinoma.

Authors:  P Lapunzina; I Badia; C Galoppo; E De Matteo; P Silberman; A Tello; J Grichener; R Hughes-Benzie
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

6.  The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.

Authors:  J Kleeff; T Ishiwata; A Kumbasar; H Friess; M W Büchler; A D Lander; M Korc
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

7.  Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.

Authors:  D F Cano-Gauci; H H Song; H Yang; C McKerlie; B Choo; W Shi; R Pullano; T D Piscione; S Grisaru; S Soon; L Sedlackova; A K Tanswell; T W Mak; H Yeger; G A Lockwood; N D Rosenblum; J Filmus
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

8.  Somatic glypican 3 (GPC3) mutations in Wilms' tumour.

Authors:  G R M White; A M Kelsey; J M Varley; J M Birch
Journal:  Br J Cancer       Date:  2002-06-17       Impact factor: 7.640

Review 9.  Prenatal case of Simpson-Golabi-Behmel syndrome with a de novo 370Kb-sized microdeletion of Xq26.2 compassing partial GPC3 gene and review.

Authors:  Jing Liu; Qin Liu; Shuting Yang; Na Ma; Jialun Pang; Ying Peng; Hui Xi; Zhengjun Jia; Yingchun Luo; Meiping Jiang; Yanling Teng; Wenxian Yu; Zhuo Li; Hua Wang
Journal:  Mol Genet Genomic Med       Date:  2021-07-22       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.